New SEC Form D filing

Aqur Biosciences, Inc., 2026-09-18

A new SEC Form D private-offering notice from Westlake Village, CA, a $1,500,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Aqur Biosciences, Inc. site↗ Verified via SEC Form D

Preclinical biopharmaceutical company developing AQR-008, an oral small molecule PCSK9 inhibitor to lower LDL cholesterol

New filing todayFiled to raise $1,500,000First money in 2026-09-03Raised so far $1,500,000HQ (as filed) Westlake Village, CASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified aqurbiosciences.com↗Named in the filing 5 executives & directors
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source